CHRDL1 inhibits OSCC metastasis via MAPK signaling-mediated inhibition of MED29.

MLA

Huang, Songkai, et al. “CHRDL1 Inhibits OSCC Metastasis via MAPK Signaling-Mediated Inhibition of MED29.” Molecular Medicine (Cambridge, Mass.), vol. 30, no. 1, Oct. 2024, p. 187. EBSCOhost, https://doi.org/10.1186/s10020-024-00956-y.

APA

Huang, S., Zhang, J., Qiao, Y., Pathak, J. L., Zou, R., Piao, Z., Xie, S., Liang, J., & Ouyang, K. (2024). CHRDL1 inhibits OSCC metastasis via MAPK signaling-mediated inhibition of MED29. Molecular Medicine (Cambridge, Mass.), 30(1), 187. https://doi.org/10.1186/s10020-024-00956-y

Chicago

Huang, Songkai, Junwei Zhang, Yu Qiao, Janak Lal Pathak, Rui Zou, ZhengGuo Piao, ShiMin Xie, Jun Liang, and Kexiong Ouyang. 2024. “CHRDL1 Inhibits OSCC Metastasis via MAPK Signaling-Mediated Inhibition of MED29.” Molecular Medicine (Cambridge, Mass.) 30 (1): 187. doi:10.1186/s10020-024-00956-y.